Page 277 - Cardiac Nursing
P. 277

Pa
                                        M
                                          Pa
                                          Pa
                                        M
                        66.
                        66.
                      5-2
                      5-2
                                              53
                                              53
                                                A
                                                A
                                            e 2
                                           g
                                           g
                                            e 2
                                           g
                          q
                                    1
                                   1
                                /09
                                /09
                                   1
                                     1 P
                                     1 P
                                   0:2
                                   0:2
                           xd
                           xd
                          q
                          q
                             6
                              /29
                                /09
                             6
                              /29
                                                 p
                    24
                    24
                   p
                                                      c.
                                                    In
                                                    In
                                                      c.
         LWBK340-c11_
         LWB
         LWB K34 0-c 11_ pp245-266.qxd  6/29/09  10:21 PM  Page 253 Aptara Inc.
            K34
                   p
                 11_
               0-c
                                                   a
                                                  ara
                                                   a
                                                   a
                                                   a
                                                 p
                                                 p
                                                  t
                                                  ara
                                                  t
                                                                        C HAPTER 11 / Laboratory Tests Using Blood  253
                                                                       level obtained in the hospital may be substantially lower than is
                   Table 11-3 ■ LIPID PROFILE REFERENCE RANGES         usual for the patient. 13  See Chapter 36 for comprehensive evalu-
                                                                       ation of lipids.
                   Lipid Profile
                   Total blood cholesterol
                     Desirable                           200 mg/dL       ADDITIONAL LABORATORY
                     Borderline high                    200–239 mg/dL    TESTS ASSOCIATED WITH
                     High                                240 mg/dL
                   HDL-C-cholesterol                                     CARDIAC DISEASE
                     Low- A major risk factor for CHD    40 mg/dL
                     Better                             40–59 mg/dL    Nearly half of all patients with known CHD have no established
                     High- Considered protective against heart disease   60 mg/dL
                                                                       coronary risk factors (i.e., hypertension, hypercholesterolemia,
                   LDL-C-cholesterol                                   cigarette smoking, diabetes mellitus, marked obesity, and physical
                     Goal for very high risk patients    70 mg/dL
                     Optimal                             100 mg/dL     inactivity). Atherosclerosis is now considered an inflammatory
                     Near or above optimal              100–129 mg/dL  disease, with cytokines and other bioactive molecules involved in
                     Borderline High                    130–159 mg/dL  most steps of the atherogenesis process (see Chapter 5).
                     High                               160–189 mg/dL    With the knowledge that atherosclerosis is an inflammatory
                     Very High                           190 mg/dL
                                                                       disease, researchers are studying different markers to determine if
                   LDL-C-cholesterol treatment goals                   there are other independent risk factors for the disease and if these
                     No CHD or DM with one or no risk factors   160 mg/dL
                     No CHD or DM with two or more risk factors   130 mg/dL  markers can be used to identify high risk individuals for CHD
                     Very high-risk patients—CHD or DM patients   70 mg/dL  that may not have traditional risk factors. Markers being studied
                                                                       include but are not limited to adhesion molecules, C-reactive pro-
                   Triglyceride
                     Normal                              150 mg/dL     tein (CRP), cytokines, fibrinogen, homocysteine (Hcy), lipoprotein-
                     Borderline High                    150–199 mg/dL  associated phospholipase A 2 , serum amyloid A, tissue-type plas-
                     High                               200–499 g/dL   minogen activator, and white blood cell (WBC) count. Hcy is
                     Very High                           500 mg/dL
                                                                       being researched extensively and is utilized as a possible risk factor
                                                                       for CHD. CRP is showing promise from a clinical chemistry per-
                   CHD, coronary heart disease; DM, diabetes mellitus.  spective and research perspective as a risk factor for CHD. 44
                   From Executive Summary of The Third Report of The National Cholesterol Education
                    Program (NCEP). (2001). Expert Panel on Detection, Evaluation, and Treatment of
                    High Blood Cholesterol in Adults (Adult Treatment Panel III), by National Choles-
                    terol Education Program. JAMA, 285, 2486–2497 and Grundy, S. M., Cleeman, J. I.,  C-Reactive Protein
                    Merz, N. B., et al. (2004). Implications of recent clinical trials for the National Cho-
                    lesterol Education Program Adult Treatment Panel III Guidelines. Circulation, 110,  CRP is an acute-phase reactant protein that is produced primarily by
                    227–239.                                           the liver during the acute inflammatory process. CRP is a nonspecific
                                                                       but sensitive indicator of inflammation, bacterial infection, or
                    DISPLAY 11-2 Computation Formulas
                    Computation of LDL Cholesterol
                    Friedewald Formula*
                    LDL cholesterol    total cholesterol   HDL cholesterol   (triglycerides divided by 5)
                    Computation of Ionized Calcium
                    Serum calcium can be presumed to be normal if:
                    (4.5   albumin level)   (0.8) 
 lab value for total calcium   8.8 to 11.0 mEq/L
                    1. Obtain total calcium level (normal   8.8 to 10.5 mEq/L). If it is less than normal (e.g.,  8.8 mEq/L), follow the steps
                    below.
                    2. Obtain serum albumin level (normal   4.5 g/dL).
                    3. If serum albumin level is decreased, subtract the decreased level from normal value for albumin (e.g., albumin level is
                    measured at 3.0; 4.5 [normal]   3.0 [measured]    1.5).
                    4. For every 1.0 decrease in albumin, add 0.8 to calcium level (e.g., for above example, 1.5   0.8   1.2).
                    5. Add the calculated figure to the total calcium level (e.g., 7.8 
 1.2    9 mEq/L, calcium is within normal range).
                    6. One-half of this level (9/2) is 4.5, within the normal range for ionized calcium (normal ionized calcium    4.5 to 5.0).
                    Computation of Anion Gap
                    Anion gap   [sodium (140) 
 potassium (4.0)]   [bicarbonate (24) 
 chloride (110)]   10 to 12 mEq/L
                    Computation of Serum Osmolality
                    Two times the serum sodium 
 serum glucose (Glu) divided by 18 
 blood urea nitrogen (BUN) divided by 1.8    serum
                    osmolality ([2   sodium] 
 [glucose/18] 
 [BUN/1.8])    280 to 300 mOsm/kg
                    (e.g., (2   122) 
 (198/2) 
 (18/1.8)    265 mOsm (water or intracellular fluid excess); (2   155) 
 (108/2) 
 (5.4/1.8)   318
                    mOsm [water or intracellular fluid deficit])
                   *Formula valid for estimating LDL cholesterol if the triglyceride level is  400 mg/dL.
   272   273   274   275   276   277   278   279   280   281   282